AL
HBI

Aspiriant LLC’s Hanesbrands HBI Stock Holding History

Aspiriant LLC’s Portfolio HBI Stock Details HBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,332
Closed -$40.9K – 311
2023
Q3 		$40.9K Sell
10,332
-2
-0% -$10 ﹤0.01% 277
2023
Q2 		$46.9K Hold
10,334
– – ﹤0.01% 279
2023
Q1 		$54.4K Hold
10,334
– – ﹤0.01% 273
2022
Q4 		$65.7K Buy
10,334
+334
+3% +$2.29K ﹤0.01% 273
2022
Q3 		$70K Sell
10,000
-1,000
-9% -$9.82K ﹤0.01% 259
2022
Q2 		$113K Buy
+11,000
New +$137K 0.01% 266

Other funds holding HBI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
LC
Loews Corp New York $11.9B AUM 8.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Aspiriant LLC's HBI Position: Q4 2023 in Review

Aspiriant LLC sold out of Hanesbrands (HBI) in Q4 2023, closing a stake of 10,332 shares — an estimated $40.9K sold.

Aspiriant LLC first reported a position in HBI in Q2 2022 and held it in 6 quarters. The position peaked at $113K in Q2 2022. 421 funds tracked by Wall St. Rank hold HBI as of Q4 2023.

  • Aspiriant LLC reported no remaining Hanesbrands position as of Q4 2023 after selling out during the quarter.
  • Aspiriant LLC sold 10,332 Hanesbrands shares in Q4 2023, an estimated $40.9K.
  • Aspiriant LLC first reported a position in Hanesbrands in Q2 2022 and held it in 6 quarters.
  • Aspiriant LLC's Hanesbrands position peaked at $113K in Q2 2022.
  • 421 funds tracked by Wall St. Rank held Hanesbrands as of Q4 2023.

Based on Aspiriant LLC's 13F filing for Q4 2023, filed 26 Jan 2024.